Russian Minister of Health Mikhail Murashko said that the Ministry of Health has given permission to conduct clinical trials of a new drug that will neutralize botulinum toxin A, developed by the NF Gamaleya National Research Center of Epidemiology and Microbiology. writes about this TASS said the department’s press service.
“This is a drug based on monoclonal antibodies that can bind to the toxin in the patient’s blood,” the message says.
According to the minister, during clinical trials, experts will need to evaluate the safety of the drug, its timing and methods of excretion from the body. Only then will the drug begin to be tested on patients infected with botulism.
On June 21, he was named head of the Department of Infectious Diseases of the Russian National Research Medical University. Pirogov Vladimir Nikiforov reported that he received the name of scientists from the Center. Gamaleya has developed a new drug based on antibodies to botulinum toxin for the urgent prevention and treatment of the disease. The new drug has an advantage because it is easier to tolerate and has minimal side effects.
Before him Murashko statedHe said there are currently 301 Russians diagnosed with botulism in hospitals, and 43 of them are on ventilators.
Formerly a doctor saidWhich foods cause botulism?